000			01692 a2200457 4500
005			20250512030018.0
264		0	_c19880510
008			198805s 0 0 eng d
022			_a0006-2952
024	7		_a10.1016/0006-2952(88)90782-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aCroset, M
245	0	0	_aInhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE. _h[electronic resource]
260			_bBiochemical pharmacology _cApr 1988
300			_a1275-80 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
650	0	4	_aAnimals
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aDocosahexaenoic Acids _xpharmacology
650	0	4	_aFatty Acids, Unsaturated _xpharmacology
650	0	4	_aFemale
650	0	4	_aGuinea Pigs
650	0	4	_aHumans
650	0	4	_aHydroxyeicosatetraenoic Acids _xpharmacology
650	0	4	_aIn Vitro Techniques
650	0	4	_aMale
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aRabbits
650	0	4	_aReceptors, Prostaglandin _xdrug effects
650	0	4	_aReceptors, Thromboxane
650	0	4	_aStructure-Activity Relationship
650	0	4	_aThromboxane A2 _xantagonists & inhibitors
650	0	4	_aVasoconstriction
700	1		_aSala, A
700	1		_aFolco, G
700	1		_aLagarde, M
773	0		_tBiochemical pharmacology _gvol. 37 _gno. 7 _gp. 1275-80
856	4	0	_uhttps://doi.org/10.1016/0006-2952(88)90782-4 _zAvailable from publisher's website
999			_c2971431 _d2971431